11.14.2024

Pharmaceutical producer Biofarm Bucuresti (stock symbol: BIO) ended the first nine months of 2024 with net profit of RON73.25 million, at an individual level, up 4.7% from the same period of 2023, as more

08.22.2024

Pharmaceutical producer Biofarm Bucuresti (stock symbol: BIO) ended the first half of 2024 with net profit of RON42 million, down 17% from RON50.2 million reported in the same period of 2023, as per more

05.14.2024

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) ended the first three months of 2024 with net profit of RON20.6 million, down almost 35% from the same period of 2023, as per its quarterly financial more

04.24.2024

In their ordinary general meeting of April 24, the shareholders of pharmaceutical producer Biofarm Bucuresti (BIO.RO) approved, among others, the financial statements for 2023, the budget of revenue more

03.20.2024

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has called shareholders to approve, among others, the distribution of RON30.5 million dividends from 2023 net profit. more

12.18.2023

Biofarm, a top five drug manufacturer locally, plans to expand on other foreign markets, both in and outside Europe. more

11.14.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) announced in its financial report released on Nov 14 that its sales income grew by 9.7% on the year to RON229 million in the first nine months of more

10.05.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has informed the local capital market in a report about the decisions taken at the Extraordinary General Meeting of Shareholders of October 5, among more

09.12.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) has sold a plot of land to the company Iancu de Hunedoara Residence SRL for approximately EUR5 million. more

08.12.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) reported a profit of RON50.1 million for January-June 2023, up 15% from RON43.6 million reported for the same period of 2022. more

05.11.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO) estimates a turnover of approximately RON325 million for 2023, up 17% versus 2022 level, and a 6% higher net profit compared to 2022 when it reported more

04.10.2023

Pharmaceutical producer Biofarm Bucuresti (BIO.RO), the fifth largest drug producer in Romania, has budgeted revenue of RON325 million for 2023, which translates into a 17% increase compared to the more

03.21.2023

Pharmaceutical producer Biofarm (BIO.RO) has called shareholders for April 26, 2023 to approve distribution of the 2022 net profit and of the RON0.03 per share gross dividend, reports to the more

02.27.2023

Drug manufacturer Biofarm (BIO.RO) on Monday (Feb 27) reported a turnover of RON277 million for 2022, up 16% from 2021, and a net profit of RON70.9 million, up 18% on the year. more

11.14.2022

Drug manufacturer Biofarm (BIO.RO) recorded a net profit of RON65.7 million in the first nine months of 2022, an increase of 20% on the previous year, according to ZF calculations based on data more

09.30.2022

Pharmaceutical manufacturer Biofarm (BIO.RO) has reached total investments of over EUR44 million in its new plant inaugurated in capital Bucharest in 2021, which is the largest greenfield investment more

03.28.2022

Pharmaceutical manufacturer Biofarm (BIO.RO) expects 16% higher revenue compared with RON239 million of 2021, as well as 15% higher EBITDA from about RON82 million last year. more

03.24.2022

Romanian drug maker Biofarm, a major player on the local market, plans to double turnover within the next 5-7 years after having opened a new drug plant in Bucharest last year in the wake of EUR35 more

02.28.2022

Romanian pharmaceutical products manufacturer Biofarm (BIO.RO) on Monday said it ended 2021 with a turnover of RON239 million, up 10% on the year, and a net profit of RON60 million, up 11% from 2020. more

01.06.2022

Romanian-held pharmaceutical products manufacturer Biofarm, the fifth largest player on this market by turnover, plans to add internally-developed products to its portfolio, especially as the company more

11.23.2021

Pharmaceutical manufacturer Biofarm Bucuresti plans to double turnover and focus more on exports in the coming years, according to Catalin Vicol, the company’s general manager. more

11.02.2021

Pharmaceutical manufacturer Biofarm (BIO.RO) has inaugurated a new pharmaceutical manufacturing and testing facility in capital Bucharest, which entailed an investment of over EUR35 million. more

10.27.2021

Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) on Wednesday said it registered an aggregate growth of 8% in turnover and of 15% in profit during 2017 – 2020 period. more

04.29.2021

Pharmaceutical manufacturer Biofarm (BIO.RO) has budgeted RON47.4 million (almost EUR10 million) for investments in 2021, most of which or about 70% will go towards equipping the new production more

04.26.2021

Shareholders of Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) on Monday approved the company's plans to distribute dividends totaling RON21.7 million. more